Key Points Interested in Astrazeneca Plc? Here are five stocks we like better. Wainua failed its CARDIO-TTRansform Phase 3 trial by showing no additive benefit for patients already taking ...

US FDA approves Pfizer & Astellas’ Padcev plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility: New York Monday, July 13, 2026, 13:00 ...

Medically reviewed by Renee Nilan, MD Key Takeaways COVID arm rash is a mild reaction that usually appears a week after the ...

Pfizer (PFE) stock, Alnylam (ALNY) stock and BridgeBio (BBIO) stock jump after a trial setback for an ATTE-CM drug from Astra ...

The buckling of two support columns at the former Pfizer headquarters in Midtown Manhattan on Tuesday morning rattled more ...

A former Pfizer building in Midtown Manhattan faces collapse risk due to structural issues, prompting evacuations of nearby ...

PADCEV (enfortumab vedotin-ejfv) can cause severe and fatal cutaneous adverse reactions including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which occurred predominantly ...

A contraceptive used by hundreds of thousands of British women could be causing brain tumours. Grace Fynn meets two women who ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced the closing of its license agreement for VEPPANUTM ...

Pfizer has received approval from the FDA for an expanded indication of Hympavzi for the treatment of haemophilia A or B.

There are actually two factors to consider in the current drawdown. The first is the massive stock price spike that occurred during the coronavirus pandemic. Pfizer was one of a small number of ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...